You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Chemoradiation

Showing 1 - 25 of 1,748
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Locally Advanced Vulvar Carcinoma, Squamous Cell Carcinoma of the Vulva Trial (Paclitaxel and Carboplatin, Chemoradiation)

Not yet recruiting
  • Locally Advanced Vulvar Carcinoma
  • Squamous Cell Carcinoma of the Vulva
  • Paclitaxel and Carboplatin
  • Chemoradiation
  • (no location specified)
Jun 6, 2023

Esophageal Cancer Trial in Tianjin (Arm A, Arm B)

Not yet recruiting
  • Esophageal Cancer
  • Arm A
  • Arm B
  • Tianjin, Tianjin, China
    Tianjin Cancer Hospital
Sep 24, 2023

Lung Cancer Trial in Palo Alto (Hypofractionated accelerated radiation therapy)

Not yet recruiting
  • Lung Cancer
  • Hypofractionated accelerated radiation therapy
  • Palo Alto, California
    Stanford University
Oct 11, 2023

NSCLC, Consolidation Immunotherapy, Radiotherapy or Sequential Chemoradiation Trial in Beijing (Tislelizumab)

Recruiting
  • Non-small Cell Lung Cancer
  • +2 more
  • Beijing, China
    Peking University Cancer Hospital and Institute
Mar 4, 2023

NSCLC Trial in Jinan (TQB3728 tablets, TQB2450 injection, sequential or concurrent chemoradiation, TQB2450 injection, sequential

Not yet recruiting
  • Non-small Cell Lung Cancer
  • TQB3728 tablets, TQB2450 injection, sequential or concurrent chemoradiation
  • TQB2450 injection, sequential or concurrent chemoradiation
  • Jinan, Shandong, China
    Cancer Hospital Affiliated to Shandong First Medical University
May 5, 2023

Gastroesophageal Junction Adenocarcinoma Trial in Beijing (Serplulimab)

Recruiting
  • Gastroesophageal Junction Adenocarcinoma
  • Beijing, China
    Peking Union Medical College Hospital
Jun 15, 2023

Head Neck Cancer Patients, Lean Body Mass, Body Composition Changes Trial in Odense C (DXA scan, Physical testing)

Completed
  • Head and Neck Cancer Patients
  • +2 more
  • DXA scan
  • Physical testing
  • Odense C, Southern Denmark Region, Denmark
    Odense University Hospital
May 25, 2023

Neoadjuvant Chemoradiation Therapy, Rectal Cancer, Immunotherapy Trial in Shanghai (xintilimab injection, Control)

Recruiting
  • Neoadjuvant Chemoradiation Therapy
  • +3 more
  • xintilimab injection
  • Control
  • Shanghai, Shanghai, China
    Department of Colorectal Surgery in Changhai Hospital
Aug 5, 2022

Esophageal Squamous Cell Carcinoma Trial in Wuhan (Intensity-modulated radiotherapy (IMRT), Tislelizumab, Cisplatin)

Not yet recruiting
  • Esophageal Squamous Cell Carcinoma
  • Intensity-modulated radiotherapy (IMRT)
  • +3 more
  • Wuhan, Hubei, China
    Renmin hosptial of Wuhan University
Jun 16, 2023

Esophageal Squamous Cell Carcinoma Trial (AK104)

Not yet recruiting
  • Esophageal Squamous Cell Carcinoma
  • (no location specified)
Oct 25, 2022

Cervical Cancer Trial in Chongqing (salvage surgery)

Recruiting
  • Cervical Cancer
  • salvage surgery
  • Chongqing, Chongqing, China
    Chongqing Cancer Hospital
Feb 20, 2023

Oncology Trial in Nijmegen (combined aerobic exercise + resistance exercise intervention (AE + RE), Aerobic exercise prior to

Recruiting
  • Oncology
  • combined aerobic exercise + resistance exercise intervention (AE + RE)
  • Aerobic exercise prior to daily radiotherapy sessions (ExPR)
  • Nijmegen, Gelderland, Netherlands
    Radboud Institute for Health Science
Jan 8, 2023

Esophageal Squamous Cell Carcinoma, Tislelizumab, Chemoradiation Trial in Nanjing (Tislelizumab, Paclitaxel, Carboplatin)

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • +2 more
  • Nanjing, Jiangsu, China
    Jiangsu Cancer Institute & Hospital
May 24, 2022

Oral Mucositis Trial (RRx-001, Intensity Modulated Radiation Therapy (IMRT), Cisplatin for injection 100 mg/m2)

Not yet recruiting
  • Oral Mucositis
  • (no location specified)
Jul 31, 2023

Lung Cancer Stage III Trial in New Brunswick (AN0025)

Not yet recruiting
  • Lung Cancer Stage III
  • Atlanta, Georgia
  • +1 more
Nov 2, 2022

Endometrial Cancer Trial in Houston (Paclitaxel, Carboplatin, Dostarlimab)

Not yet recruiting
  • Endometrial Cancer
  • Houston, Texas
    M D Anderson Cancer Center
Apr 6, 2023

Cancer of Rectum Trial in New Brunswick (combination of drugs (chemoradiation (capecitabine and radiation) + FOLFOXIRI

Recruiting
  • Cancer of Rectum
  • combination of drugs (chemoradiation (capecitabine and radiation) + FOLFOXIRI (Oxaliplatin, leucovorin, irinotecan, and fluorouracil)
  • Lakewood, New Jersey
  • +4 more
Nov 2, 2022

HPV-Related Squamous Cell Carcinoma, Squamous Cell Carcinoma of the Oral Cavity, Squamous Cell Carcinoma of the Larynx Trial in

Not yet recruiting
  • HPV-Related Squamous Cell Carcinoma
  • +4 more
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center, Case Comprehensiv
Jan 31, 2023

Esophageal Cancer Trial in Rotterdam (Nivolumab)

Not yet recruiting
  • Esophageal Cancer
  • Rotterdam, Netherlands
    Erasmus MC
Aug 4, 2022

High Grade Glioma Trial in Cleveland (procedure, radiation, drug)

Recruiting
  • High Grade Glioma
  • LITT
  • +2 more
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer institute, Case Comprehensive Ca
Jan 5, 2023

Lung Cancer Trial in Groningen (Radiotherapy)

Recruiting
  • Lung Cancer
  • Radiotherapy
  • Groningen, Netherlands
    University Medical Center Groningen
May 19, 2022

Stage IIIA NSCLC Trial in Cleveland (Cisplatin, Etoposide, Pembrolizumab)

Terminated
  • Stage IIIA Non-Small Cell Lung Cancer
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Dec 15, 2022

Cardiotoxicity in Locally Advanced Lung Cancer Patients Treated

Enrolling by invitation
  • Cardiotoxicity
  • +3 more
  • Chemoradiation
  • Birmingham, Alabama
  • +6 more
Nov 1, 2022

Locally Advanced Head and Neck Squamous Cell Carcinoma Trial in Columbus (Counseling, Dietary Counseling and Surveillance,

Active, not recruiting
  • Locally Advanced Head and Neck Squamous Cell Carcinoma
  • Counseling
  • +4 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Jan 5, 2023

Pancreatic Cancer Trial (Chemotherapy, Radiation)

Active, not recruiting
  • Pancreatic Cancer
  • (no location specified)
May 30, 2022